Prescription Medication Use Among Community-Based U.S. Adults With Chronic Low Back Pain: A Cross-Sectional Population Based Study
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Many classes of medications have been evaluated in chronic low back pain (cLBP), however their utilization in the community remains unclear. We examine patterns of prescription medication use among Americans with cLBP in a nationally representative, community-based sample. The Back Pain Survey was administered to a representative sample of US adults aged 20–69 (N = 5103) during the 2009–2010 cycle of the National Health and Nutrition Examination Survey (NHANES). cLBP was defined as self-reported pain in the area between the lower posterior margin of the ribcage and the horizontal gluteal fold on most days for at least 3 months (N = 700). Home-based interviews with pill bottle verification were used to capture commonly prescribed medications for chronic pain. Among the sample of US adults with cLBP aged 20–69, 36.9% took at least one prescription pain medication in the past 30 days. 18.8% used opioids, 9.7% NSAIDs, 8.5% muscle relaxants, 6.9% gabapentin or pregabalin. Non-pain antidepressants and hypnotics were used by 17.8% and 4.7%, respectively. Opioids were used long-term in 76.9% of cases (median 2 years) and were frequently co-administered with antidepressants, benzodiazepines, or hypnotics. 94% of prescription opioids in the cLBP population were used by subjects with less than a college education. Opioids were the most widely used prescription analgesic class in community-based US adults with cLBP and were often co-administered with other CNS-active medications. Opioid use was highly prevalent among less educated Americans with cLBP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · JAMA · doi:10.1001/jama.2016.1464 · Cited by 5,161
Qaseem, A., Wilt, T. J., McLean, R. M., Forciea, M. A., & for the Clinical Guidelines Committee of the American College of Physicians* (2017) · Annals of Internal Medicine · doi:10.7326/m16-2367 · Cited by 3,234
Chou, R., Qaseem, A., Snow, V., Casey, D., Cross, J. T., Shekelle, P., Owens, D. K., & for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians and the American College of Physicians/American Pain Society Low Back Pain Guidelines Panel* (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00006 · Cited by 2,718
Chou, R., Turner, J. A., Devine, E. B., Hansen, R. N., Sullivan, S. D., Blazina, I., Dana, T., Bougatsos, C., & Deyo, R. A. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2559 · Cited by 1,606
Expenditures and health status among adults with back and neck problems
Martin, B. I. (2008) · JAMA · doi:10.1001/jama.299.6.656 · Cited by 1,531 · cited 1×
“Various medications, including opioids, are widely prescribed for chronic low back pain in the US despite limited supporting evidence, high costs, and often serious health risks [28, 49].”
BackgroundThe unequal burden of pain: confronting racial and ethnic disparities in pain
Green, C. R., Anderson, K. O., Baker, T. A., Campbell, L. C., Decker, S., Fillingim, R. B., Kaloukalani, D. A., Lasch, K. E., Myers, C., Tait, R. C., et al. (2003) · Pain Medicine · doi:10.1046/j.1526-4637.2003.03034.x · Cited by 1,248
Vital signs: changes in opioid prescribing in the United States, 2006-2015.
Guy, G. P., Zhang, K., Bohm, M. K., Losby, J., Lewis, B., Young, R., Murphy, L. B., & Dowell, D. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6626a4 · Cited by 1,117
Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects
Furlan, A. D. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.051528 · Cited by 873
Report of the NIH Task Force on research standards for chronic low back pain.
Deyo, R. A., Dworkin, S. F., Amtmann, D., Andersson, G., Borenstein, D., Carragee, E., Carrino, J., Chou, R., Cook, K., DeLitto, A., et al. (2014) · The Journal of Pain · doi:10.1016/j.jpain.2014.03.005 · Cited by 533
Ungprasert, P., Cheungpasitporn, W., Crowson, C. S., & Matteson, E. L. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.03.008 · Cited by 322
Turner, B. J., & Liang, Y. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3199-4 · Cited by 109
An update on the representational approach to patient education.
Donovan, H. S., Ward, S. E., Song, M., Heidrich, S. M., Gunnarsdottir, S., & Phillips, C. M. (2007) · Journal of Nursing Scholarship · doi:10.1111/j.1547-5069.2007.00178.x · Cited by 90 · cited 1×
“Patient education strategies that include assessment of patients’ health literacy and post-intervention knowledge have been effective in changing pain perception, ensuring correct pain medication dosing, and promoting safe storage and disposal of prescription opioids [40, 11, 30].”
Background
Cited by
The silent epidemic of chronic pain in older adults
Domenichiello, A. F., & Ramsden, C. E. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.04.006 · Cited by 434
Cardiovascular effects and safety of (non-aspirin) NSAIDs
Schjerning, A.-M., McGettigan, P., & Gislason, G. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0366-z · Cited by 387
Cui, D., Janela, D., Costa, F., Molinos, M., Areias, A. C., Moulder, R. G., Scheer, J. K., Bento, V., Cohen, S. P., Yanamadala, V., et al. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00870-3 · Cited by 60
Haghbin, H., Zakirkhodjaev, N., Husain, F. F., Lee-Smith, W., & Aziz, M. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07788-y · Cited by 26
Metadata
- Authors
- Shmagel, A., Ngo, L., Ensrud, K., & Foley, R.
- Venue
- The Journal of Pain
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 19
- Issue
- 10
- Pages
- 1104-1112
- ISSN
- 1526-5900 (ISSN-L)
- OpenAlex
- W2799781765
- Cited by
- 71
- References
- 12
- FWCI
- 7.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.